Assessing the residual activity of germ-line BRCA2 mutations by novel malignancy risk prediction score

被引：0
|
作者：
Radulovic, Ivana [1 ]
Schundeln, Michael [1 ]
Muller, Lisa [1 ]
Ptok, Johannes [2 ]
Honisch, Ellen [2 ,3 ]
Niederacher, Dieter [3 ]
Schaal, Heiner
Wiek, Constanze
Hanenberg, Helmut [1 ,4 ]
机构：
[1] Univ Hosp Essen, Univ Duisburg Essen, Dept Pediat III, Essen, Germany
[2] Univ Hosp Dusseldorf, Heinrich Heine Univ Duesseldorf, Inst Virol, Dusseldorf, Germany
[3] Univ Hosp Dusseldorf, Heinrich Heine Univ Dusseldorf, Dept Gynecol & Obstet, Dusseldorf, Germany
[4] Univ Hosp Dusseldorf, Heinrich Heine Univ, Dept Otorhinolaryngol Head Neck Surg, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
561
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [1] BRCA2 germ-line mutations in Spanish male breast cancer patients
    Díez, O
    Cortés, J
    Domènech, M
    Pericay, C
    Brunet, J
    Alonso, C
    Baiget, M
    ANNALS OF ONCOLOGY, 2000, 11 (01) : 81 - 84
  • [2] BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use
    Grenader, T
    Peretz, T
    Lifchitz, M
    Shavit, L
    BREAST, 2005, 14 (04): : 264 - 268
  • [3] A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2
    Liede, A
    Rehal, P
    Vesprini, D
    Jack, E
    Abrahamson, J
    Narod, SA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) : 1543 - 1544
  • [4] Correlation of germ-line BRCA2 mutations with aggressive prostate cancer and outcome.
    Castro, E.
    Goh, C. L.
    Olmos, D.
    Leongamornlert, D.
    Saunders, E.
    Tymrakiewicz, M.
    Mahmud, N.
    Dadaev, T.
    Govindasami, K.
    Guy, M.
    OBrien, L.
    Sawyer, E.
    Hall, A.
    Wilkinson, R.
    Kote-Jarai, Z.
    Eeles, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Evaluating of BRCA1 and BRCA2 Germ-line Mutations and BRCA Risk Assessment of Mutation Carriers in Turkish Breast Cancer Patients
    Cecener, G.
    Egeli, U.
    Tunca, B.
    Erturk, E.
    Gokgoz, S.
    Tasdelen, I.
    Ak, S.
    Demirdogen, E.
    Tezcan, G.
    Bayram, N.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S105 - S105
  • [6] A BRCA2 germ-line mutation in familial pancreatic carcinoma
    White, K
    Held, KR
    Weber, HF
    INTERNATIONAL JOURNAL OF CANCER, 2001, 91 (05) : 742 - 744
  • [7] Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer
    Hakansson, S
    Johannsson, O
    Johansson, U
    Sellberg, G
    Loman, N
    Gerdes, AM
    Holmberg, E
    Dahl, N
    Pandis, N
    Kristoffersson, U
    Olsson, H
    Borg, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (05) : 1068 - 1078
  • [8] Predictors and prevalence of germ-line BRCA1 and BRCA2 mutations in high-risk patients screened at a community hospital
    Riaz, S. S.
    Ahsan, S.
    Bloom, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
    Tirkkonen, M
    Johannsson, O
    Agnarsson, BA
    Olsson, H
    Ingvarsson, S
    Karhu, R
    Tanner, M
    Isola, J
    Barkardottir, RB
    Borg, A
    Kallioniemi, OP
    CANCER RESEARCH, 1997, 57 (07) : 1222 - 1227
  • [10] The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer
    Gayther, SA
    de Foy, EAF
    Harrington, P
    Pharoah, P
    Dunsmuir, WD
    Edwards, SM
    Gillett, C
    Ardern-Jones, A
    Dearnaley, DP
    Easton, DF
    Ford, D
    Shearer, RJ
    Kirby, RS
    Dowe, AL
    Kelly, J
    Stratton, MR
    Ponder, BAJ
    Barnes, D
    Eeles, RA
    CANCER RESEARCH, 2000, 60 (16) : 4513 - 4518
12345